Paradoxical adverse drug reactions (ADRs) are defined as being opposing reactions to the pharmacological effect of drugs in relation to its pharmacodynamic properties. Their diagnosis is difficult as they are relatively rare with atypical clinical presentation (with the possibility of being confused with drug ineffectiveness or the worsening of the underlying disease). This kind of ADR may be particularly subject to under-notification. The aim of the present study is to describe paradoxical ADRs using the French PharmacoVigilance DataBase (FPVDB).
We analysed all reports recorded in the FPVDB with drugs defined as “suspect” and which included the term “paradoxical reaction” (PR) (according to MedDRA classification) from 01/01/1984 to 12/31/2018. The drugs were classified according to the Chemical Therapeutic Anatomical Classification (ATC).
We found 57 reports of PR, with half of them recorded between 2015 and 2018. The median age of patients was 46 years, mainly male (54%). The most frequently involved drugs were immunomodulating agents (n = 28, 49%) and psychotropics (n = 28, 49%). The leading paradoxical ADRs were psychiatric (anxiety, sleep and behavioural disorders) and skin-related. In 19 cases (33%), PR was related to benzodiazepines mainly occurring in patients in extreme ages (five cases in children and patients > 70, respectively, 53%). For psychotropic-induced PR (n = 28), known contributory factors (alcohol consumption, underlying psychiatric diseases) were found in 18 cases (64%). Paradoxical reactions with immunomodulating agents were mainly related to skin ADRs (n = 25). For psychotropics, paradoxical ADRs occurred rapidly after a mean delay of 1 day, predominantly following high doses. We also identified several “unexpected” paradoxical reactions, such as cognitive degradation with donepezil, or a return to impulsive smoking addiction with varenicline.
This study highlights that pharmacovigilance databases like the French database make it possible to investigate the main characteristics of paradoxical reactions to drugs. This ADR was mainly found in the FPVDB with psychotropic drugs and immunomodulating agents. Moreover, pharmacovigilance databases enable the identification of some signs of “unexpected paradoxical reactions”. In order to identify this type of ADR more effectively, work on awareness and harmonization is required to register these reports. The addition of the term “paradoxical reaction to the drug” to the list of other symptoms would facilitate their identification and analysis.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Smith SW, Hauben M, Aronson JK (2012) Paradoxical and bidirectional drug effects. Drug Saf 35:173–189
Hauben M, Aronson JK (2006) Paradoxical reactions: under recognized adverse effects of drugs? Drug Saf 29:911–1010
Moore N, Berdai D, Blin P, Droz C (2019) Pharmacovigilance the next chapter. Therapie 74:557–567
Introductory guide MedDRA. https://www.meddra.org/sites/default/files/guidance/file/000354_intguide_22.1.pdf. Accessed 28/10/2019
Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259
Miremont-Salamé G, Théophile H, Haramburu F, Bégaud B (2016) Imputabilité en pharmacovigilance: de la méthode française originelle aux méthodes réactualisées. Therapie 71:171–178
ATC Structure and principles. https://www.whocc.no/atc/structure_and_principles. Accessed 28/10/2019
Figueras A, Pedrós C, Valsecia M, Laporte JR (2002) Therapeutic ineffectiveness: heads or tails? Drug Saf 25:485–487
Gutierez MM, Roper J, Pockhee H (2001) Paradoxical reactions to benzodiazepines: when to expect the unexpected. Am J Nurs 101:34–39
Weinbroum AA, Szold O, Ogorek D, Flasishon R (2001) The midazolam-induced paradox phenomenon is reversible by flumazenil: epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol 18:789–797
Hall RW, Zisook S (1981) Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol 11:99–104
Davies CJ, Davies DM (2001) Paradoxical reactions to commonly used drugs. Adverse Drug React Bull 207:807–810
McKenzie WS, Rosenberg M (2010) Paradoxical reaction following administration of a benzodiazepine. J Oral Maxillofac Surg 68:3034–3036
Mancuso E, Tanzi G, Gabay M (2004) Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy 24:1177–1185
Fiorino G, Danese S, Pariente B, Allez M (2014) Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents. Autoimmun Rev 13:15–19
Joyau C, Veyrac G, Dixneuf V, Jolliet P (2012) Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect? Clin Exp Rheumatol 30:700–706
Del Giorno R, Iodice A, Mangas C, Gabutti L (2019) New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review. Ther Adv Musculoskelet Dis 11:1–6
Dika E, Varotti C, Bardazzi F, Maibach HI (2006) Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score. Cutan Ocul Toxicol 25:1–11
Hsu C, Lin C, Lu L, Hu L (2015) Risperidone exacerbates psychosis: a paradoxical phenomenon? Aust N Z J Psychiatry 49:669–670
Fonda G, MacGregorb A, Ducasseb D, Brittnerba M (2014) Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder. Psychiatry Res 216:286–287
Silvestri S, Seeman MV, Negrete JC, Houle S, Shammi CM, Remington GJ, Kapur S, Zipursky RB, Wilson AA, Christensen BK, Seeman P (2000) Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology 152:174–180
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Hakimi, Y., Petitpain, N., Pinzani, V. et al. Paradoxical adverse drug reactions: descriptive analysis of French reports. Eur J Clin Pharmacol 76, 1169–1174 (2020). https://doi.org/10.1007/s00228-020-02892-2
- Paradoxical adverse drug reactions
- Drug safety
- Immunomodulating agents